Literature DB >> 26131213

Effect of variation of FGF2 genotypes on the risk of osteosarcoma susceptibly: a case control study.

Jiefeng Wang1, Hongtao Liu1, Xiaoyang Liu1, Xiaojun Qi2.   

Abstract

OBJECTIVE: Genetic factors play an important role in osteosarcoma (OS) etiology and fibroblast growth factor 2 (FGF2) gene single polymorphisms may be involved. The aim of this study was to test whether FGF2 variants are associated with susceptibility to OS in a Chinese population.
METHODS: A total of 151 subjects who were diagnosed as OS and 225 healthy age-matched controls were enrolled in the present study. Thers11737764 C/T SNP in FGF2 gene was genotyped in all the subjects. The SPSS software was used to investigate the association between the rs11737764 genotypes and OS susceptibility or severity.
RESULTS: The genotype frequencies of the FGF2 rs11737764 C/T polymorphism were 44.4% (CC), 50.3% (CT) and 5.3% (TT) in OS patients, and 55.6% (CC), 43.1% (CT) and 1.3% (TT) in controls. Rs11737764 C/T was found to be significantly associated with increased risk and OS no matter what genetic model was used.
CONCLUSION: In conclusion, our data demonstrated the FGF2 SNP rs11737764 was significantly associated with increased osteosarcoma susceptibility in Chinese Han Population.

Entities:  

Keywords:  FGF2; SNP; osteosarcoma

Year:  2015        PMID: 26131213      PMCID: PMC4483889     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  35 in total

Review 1.  Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Authors:  S Bielack; D Carrle; P G Casali
Journal:  Ann Oncol       Date:  2009-05       Impact factor: 32.976

2.  Association of interleukin-12 polymorphisms and serum IL-12p40 levels with osteosarcoma risk.

Authors:  Junli Wang; Legen Nong; Yesheng Wei; Shanyu Qin; You Zhou; Yujin Tang
Journal:  DNA Cell Biol       Date:  2013-08-30       Impact factor: 3.311

3.  The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific.

Authors:  F Debiais; M Hott; A M Graulet; P J Marie
Journal:  J Bone Miner Res       Date:  1998-04       Impact factor: 6.741

4.  Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice.

Authors:  T Sobue; T Naganawa; L Xiao; Y Okada; Y Tanaka; M Ito; N Okimoto; T Nakamura; J D Coffin; M M Hurley
Journal:  J Cell Biochem       Date:  2005-05-01       Impact factor: 4.429

5.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation.

Authors:  A Montero; Y Okada; M Tomita; M Ito; H Tsurukami; T Nakamura; T Doetschman; J D Coffin; M M Hurley
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

6.  Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.

Authors:  Yang Liu; Zhimin He; Dapeng Feng; Guodong Shi; Rui Gao; Xiaodong Wu; Weiguo Song; Wen Yuan
Journal:  DNA Cell Biol       Date:  2011-05-25       Impact factor: 3.311

7.  Predictive potential of glutathione S-transferase polymorphisms for prognosis of osteosarcoma patients on chemotherapy.

Authors:  Shai-Lin Zhang; Ning-Fang Mao; Jun-Ying Sun; Zhi-Cai Shi; Bing Wang; Yong-Jian Sun
Journal:  Asian Pac J Cancer Prev       Date:  2012

Review 8.  Osteosarcoma: a multidisciplinary approach to diagnosis and treatment.

Authors:  James C Wittig; Jacob Bickels; Dennis Priebat; James Jelinek; Kristen Kellar-Graney; Barr Shmookler; Martin M Malawer
Journal:  Am Fam Physician       Date:  2002-03-15       Impact factor: 3.292

9.  Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma.

Authors:  Huey-En Tzeng; Chun-Hao Tsai; Zi-Ling Chang; Chen-Ming Su; Shih-Wei Wang; Wen-Li Hwang; Chih-Hsin Tang
Journal:  Biochem Pharmacol       Date:  2012-12-05       Impact factor: 5.858

10.  Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells.

Authors:  Min-Suk Kim; Chong Jai Kim; Hyun Sook Jung; Mi Ran Seo; Yong-Sung Juhnn; Hee Young Shin; Hyo Seop Ahn; Carol J Thiele; Je G Chi
Journal:  J Pathol       Date:  2004-01       Impact factor: 7.996

View more
  3 in total

1.  FGF-2 Gene Polymorphism in Osteoporosis among Guangxi's Zhuang Chinese.

Authors:  Xiaoyun Bin; Chaowen Lin; Xiufeng Huang; Qinghui Zhou; Liping Wang; Cory J Xian
Journal:  Int J Mol Sci       Date:  2017-06-27       Impact factor: 5.923

2.  Identification of key gene modules for human osteosarcoma by co-expression analysis.

Authors:  Jing Zhang; Qing Lan; Jiasheng Lin
Journal:  World J Surg Oncol       Date:  2018-05-02       Impact factor: 2.754

3.  Weighted gene co-expression network analysis revealed key biomarkers associated with the diagnosis of hypertrophic cardiomyopathy.

Authors:  Xin Li; Chenxin Wang; Xiaoqing Zhang; Jiali Liu; Yu Wang; Chunpu Li; Dongmei Guo
Journal:  Hereditas       Date:  2020-10-24       Impact factor: 3.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.